激動の医薬品業界で
将来を見据えたキャリアを築く。

Brand/Functional Planに基づきMSLアクションプランを策定・実行すること。International Medical Affairs (IMA) の一員として、Key External Expert （KEE)とのサイエンティフィック・インタラクション（科学的・相互的ディスカッション）を通じてエビデンス創出に繋げることを含め、患者の治療に大きく貢献するメディカル活動を行うことを目指す。

Manager II, Regulatory Affairs (RA) Therapeutic Area (TA) Group, Regulatory Affairs Japan, is accountable for executing regulatory activities for projects with high complexity and strategic impact, acting as a senior core member and regulatory lead within project teams. This role drives robust regulatory strategies across the product lifecycle, ensures timely and high-quality regulatory deliverables, and maintains full compliance with applicable regulations and company policies.

In addition to project execution, the Manager II supports and develops RA team members, provides technical and strategic guidance, and contributes to team management within and across therapeutic areas, strengthening overall regulatory capability and operational excellence.

スペシャルティ領域での新薬の承認取得を通して、日本の患者さんにイノベイティブな治療を提供することに貢献できる業務です。

製品および患者ニーズのエキスパートとして、専門医を訪問します。主要な顧客との長期的な関係を築き上げ、売り上げに貢献します。

Purpose
As a Study Management Associate III, you will be part of a dynamic, centralized study 
management team that is responsible for the execution of our global clinical trials and 
a key member of the study team. 
The Study Management Associate III works as an independent, contributing member 
of a cross-functional and global partnership to plan, execute and manage one or more 
Phase 0-4 clinical trials under the guidance of the Study Project Manager and SMA 
Manager. The Study Management Associate III works to ensure that assigned studies 
are executed with quality and efficiency, in accordance with timelines and budget to 
support broader company strategic objectives. The Study Management Associate III is 
expected to work in accordance with all AbbVie Ways of Working.
This is a global role and may be located virtually.